Eterna Therapeutics (ERNA) Fails to deliver data

Key failure to deliver metrics for Eterna Therapeutics:

• Last SEC data release: 2024-10-31
• Last 15 days FTD volume: €0.01 M
• Last 3 months FTD volume: €0.06 M
• Last year FTD volume: €0.06 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Eterna Therapeutics (ERNA) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Eterna Therapeutics (ERNA) - since 2022

Eterna Therapeutics (ERNA) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Baxter BAX	€11.62 M	€53.13 M	🇺🇸 USA
Geron GERN	€4.94 M	€21.28 M	🇺🇸 USA
Omeros Corporation OMER	€0.79 M	€6.65 M	🇺🇸 USA
Sanofi SNY	€11.64 M	€71.88 M	🇫🇷 France
Bio-Techne TECH	€4.37 M	€32.38 M	🇺🇸 USA
Genetic Technologies GENE	N/A	€0.03 M	🇦🇺 Australia
Teva Pharmaceutical Industries TEVA	€9.38 M	€32.19 M	🇮🇱 Israel